<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present investigation has demonstrated that it is advisable to specify different immunologic subvarieties of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> based on the detection of superficial markers of blast cells </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0006721'>Acute lymphoblastic leukemia</z:hpo> subvarieties are characterized by different clinical and hematological manifestations and differ with respect to the sensitivity to <z:chebi fb="0" ids="35610">cytostatic</z:chebi> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The duration of remissions and lifespans was different in children belonging to different groups </plain></SENT>
</text></document>